gene 720 words KG: SMPD1
Contents

SMPD1 Gene - Acid Sphingomyelinase

🧬 Gene Info
Gene SymbolSMPD1
AliasesAcid sphingomyelinase, ASM, Page for SMPD1 Gene
Chromosome11p15.4
Protein TypeEnzyme
Target ClassEnzyme
FunctionThe SMPD1 gene encodes acid sphingomyelinase (ASM), a lysosomal hydrolase enzyme that catalyzes the hydrolysis of sphingomyelin to ceramide and phosphorylcholine.
Mechanism of ActionSmall molecule inhibitor or modulator of sphingomyelinase activity
Primary Expressionneurons, astrocytes, microglia, and oligodendrocytes, with particular importance in white matter tracts
DruggabilityMedium (0.47)
Clinical StageApproved
Molecular Weight75 kDa
PathwaysSphingolipid metabolism, Lysosomal degradation, Ceramide signaling
UniProt IDP17405
NCBI Gene ID6609
Ensembl IDENSG00000166311
OMIM257200
GeneCardsSMPD1
Human Protein AtlasSMPD1
Associated DiseasesAging, Als, Alzheimer, Alzheimer's disease
Known Drugs/CompoundsOlipudase alfa
InteractionsAGING, ALPHA-SYNUCLEIN, ALS, AND, App, asah1
SciDEX TargetView Target Profile (7 clinical trials)
SciDEX HypothesesSelective Acid Sphingomyelinase Modulation Therapy
TREM2-ASM Crosstalk in Microglial Lysosomal Senesc
Senescent Cell ASM-Complement Cascade Intervention (+1 more)
KG Connections534 knowledge graph edges
DatabasesGeneCardsHPASTRING

No AI portrait yet

Knowledge Graph

Related Hypotheses (24)

Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.92
CYP46A1 Overexpression Gene Therapy
Score: 0.92
SASP-Driven Aquaporin-4 Dysregulation
Score: 0.78
Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.70
Complement C1q Mimetic Decoy Therapy
Score: 0.69

Related Analyses (9)

SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · completed
How do sphingomyelin/ceramide ratios specifically regulate B
neurodegeneration · completed
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived

Related Experiments (13)

Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.40
Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40
Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.40
Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag
clinical · proposed · Score: 0.40
Experiment: Multi-Ethnic PD GWAS
clinical · proposed · Score: 0.40

See Also (12)

ABCA7 (Redirect)
redirect · KG edge: associated_with
Apoptosis in Neurodegeneration
entity · KG edge: associated_with
Amyloid-Related Imaging Abnormalities (ARIA)
entity · KG edge: associated_with
Astrocytes
entity · KG edge: activates
Autophagy Enhancement Drug Screening for Neurodegenerat
experiment · KG edge: associated_with

Knowledge Graph (12 edges)

SMPD1 modifies ceramide_biosynthesis
NTN1 co_discussed SMPD1
HSPG2 co_discussed SMPD1
P2RY12 co_discussed SMPD1
P2RX7 co_discussed SMPD1
AQP4 co_discussed SMPD1
EPHB4 co_discussed SMPD1
SMPD1 co_discussed C1QA
SMPD1 co_discussed CERS2
SMPD1 associated_with Alzheimer's disease

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)